Reuters logo
a month ago
BRIEF-Penumbra's voluntary field removal of its 3D revascularization devices will not impact its revenue guidance
June 13, 2017 / 12:40 PM / a month ago

BRIEF-Penumbra's voluntary field removal of its 3D revascularization devices will not impact its revenue guidance

1 Min Read

June 13 (Reuters) - Penumbra Inc-

* On June 9, co initiated a voluntary field removal of four lots of its 3D revascularization devices - SEC filing

* Voluntary field removal was based on company's identification of an issue involving a raw material component of the devices

* Penumbra Inc - does not currently expect that this voluntary action will have material impact on its previously issued revenue guidance - sec filing

* The four lots of its 3d revascularization devices were distributed between May 15, 2017 and June 7, 2017 Source text: (bit.ly/2thb52M) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below